Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05257213
NA

Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy

Sponsor: Nadezhda Women's Health Hospital

View on ClinicalTrials.gov

Summary

The aim of this study is to compare the efficacy of intrauterine application of heparin solution to the use of hyaluronic acid barrier gel for the prevention of intrauterine adhesion formation after operative hysteroscopy.

Official title: Intrauterine Adhesions Prevention: the Use of Heparin Solution Compared to Application of Anti-adhesion Barrier Gel After Operative Hysteroscopy

Key Details

Gender

FEMALE

Age Range

25 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2022-02-14

Completion Date

2026-02-28

Last Updated

2025-05-21

Healthy Volunteers

No

Interventions

DRUG

Heparin solution

3 ml saline solution containing 5000 IU heparin.

DRUG

Anti-adhesion barrier gel

2 ml biodegradable barrier gel containing sodium hyaluronate (10 mg/ml), sodium chloride (8.5 mg/ml), disodium hydrogen phosphate (0.34mg/ml), sodium dihydrogen phosphate (0.14 mg/ml) and water for injection (QS to weight).

Locations (2)

Nadezhda Women's Health Hospital

Sofia, Sofia, Bulgaria

Nadezhda Women's Health Hospital

Sofia, Bulgaria